We are live on ! Find out more
CLVS

Clovis Oncology, Inc.
CLVS

Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

138 hedge funds and large institutions have $1.31B invested in Clovis Oncology, Inc. in 2014 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 58 increasing their positions, 38 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more funds holding in top 10

Funds holding in top 10: 4 → 7 (+3)

53% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 38

26% more call options, than puts

Call options by funds: $31M | Put options by funds: $24.6M

13% more capital invested

Capital invested by funds: $1.16B → $1.31B (+$147M)

8% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 25

1% less funds holding

Funds holding: 140 → 138 (-2)

Holders
138
Holders Change
-2
Holders Change %
-1.43%
% of All Funds
4%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.2%
New
23
Increased
58
Reduced
38
Closed
25
Calls
$31M
Puts
$24.6M
Net Calls
+$6.38M
Net Calls Change
+$17.3M

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$34.5M
2
PAI
Palo Alto Investors
California
+$33.7M
3
O
OppenheimerFunds
New York
+$24.2M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$15.4M
5
BA
BlackRock Advisors
Delaware
+$12.4M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$46.5M
2
BBA
Baker Bros. Advisors
New York
-$32.8M
3
Franklin Resources
Franklin Resources
California
-$19.3M
4
SAM
Sectoral Asset Management
Quebec, Canada
-$13M
5
JHIU
Janus Henderson Investors US
Colorado
-$11.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
51
Cormorant Asset Management
Massachusetts
$3.17M – – –
GTC
52
Ghost Tree Capital
New York
$2.95M +$2.72M +65,000 New
Ameriprise
53
Ameriprise
Minnesota
$2.9M +$2.49M +59,585 +1,395%
RPAM
54
Rhenman & Partners Asset Management
Sweden
$2.59M -$1.38M -33,000 -37%
Principal Financial Group
55
Principal Financial Group
Iowa
$2.53M -$10.9K -260 -0.5%
NIP
56
Nicholas Investment Partners
California
$2.36M +$69.8K +1,670 +3%
NI
57
Numeric Investors
Massachusetts
$2.17M -$4.09M -97,800 -67%
California State Teachers Retirement System (CalSTRS)
58
California State Teachers Retirement System (CalSTRS)
California
$2.07M +$19.2K +459 +1%
AllianceBernstein
59
AllianceBernstein
Tennessee
$2.04M +$29.2K +700 +2%
MIG
60
Mariner Investment Group
New York
$1.95M +$1.8M +43,000 New
FM
61
Forward Management
California
$1.95M +$824K +19,715 +64%
GACM
62
Green Arrow Capital Management
New York
$1.81M -$163K -3,900 -9%
Allianz Asset Management
63
Allianz Asset Management
Germany
$1.68M +$49.1K +1,175 +3%
DCM
64
DAFNA Capital Management
California
$1.67M +$1.54M +36,900 New
PIM
65
Partner Investment Management
California
$1.67M +$839K +20,084 +120%
TA
66
Teachers Advisors
New York
$1.57M -$1.42K -34 -0.1%
DIA
67
Denver Investment Advisors
Colorado
$1.52M -$11.6K -277 -0.8%
BCM
68
Bourgeon Capital Management
Connecticut
$1.43M +$478K +11,450 +57%
PA
69
Perceptive Advisors
New York
$1.4M +$835K +20,000 +183%
GP
70
GLG Partners
United Kingdom
$1.34M +$1.24M +29,640 New
WSA
71
Wall Street Associates
California
$1.33M -$202K -4,840 -14%
Axa
72
Axa
France
$1.28M -$7.6K -182 -0.6%
ProShare Advisors
73
ProShare Advisors
Maryland
$1.24M -$222K -5,307 -16%
American Century Companies
74
American Century Companies
Missouri
$1.14M +$152K +3,650 +17%
HVC
75
Healthcare Value Capital
New Jersey
$1.13M +$1.04M +25,000 New
1 2
3
4 5

CLVS Hedge Fund Activity: Q3 2014 in Review

138 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q3 2014, worth a combined $1.31B — up 13% from $1.16B a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of CLVS and 23 opened new positions — a net loss of 2 holders — while 38 trimmed existing stakes and 58 added.

The largest buyer was PFM Health Sciences, adding an estimated $34.5M. The largest seller was Fidelity Investments, cutting an estimated $46.5M.

  • 138 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q3 2014, down from 140 in Q2 2014.
  • Funds reported $1.31B of Clovis Oncology, Inc. stock for Q3 2014, up 13% quarter-over-quarter.
  • 23 funds opened new Clovis Oncology, Inc. positions in Q3 2014 and 25 closed out, a net change of -2 holders.
  • The largest Clovis Oncology, Inc. buyer in Q3 2014 was PFM Health Sciences, an estimated $34.5M added.
  • The largest Clovis Oncology, Inc. seller in Q3 2014 was Fidelity Investments, an estimated $46.5M sold.

Based on aggregated 13F filings for Q3 2014.